Is febrile neutropenia prophylaxis with granulocyte-colony stimulating factors economically justified for adjuvant TC chemotherapy in breast cancer?

被引：0
|
作者：
Chris Skedgel
Daniel Rayson
Tallal Younis
机构：
[1] University of East Anglia,Norwich Medical School
[2] Capital Health,Atlantic Clinical Cancer Research Unit
[3] Capital Health,Department of Medicine
来源：
Supportive Care in Cancer | 2016年 / 24卷
关键词：
Breast cancer; Febrile neutropenia; Granulocyte colony-stimulating factors; Economic evaluation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：387 / 394
页数：7
相关论文
共 50 条
  • [21] Incidence of febrile neutropenia in docetaxel chemotherapy without prophylactic granulocyte-colony stimulating factor (GCSF) for metastatic prostate cancer
    Renninson, Emily
    Closier, Philippa
    Jonnada, Sai
    CLINICAL ONCOLOGY, 2018, 30 : E1 - E1
  • [22] Incidence of febrile neutropenia in docetaxel chemotherapy without prophylactic granulocyte-colony stimulating factor (GCSF) for metastatic prostate cancer
    Renninson, Emily
    Closier, Philippa
    Jonnada, Sai
    CLINICAL ONCOLOGY, 2018, 30 : E4 - E4
  • [23] Real-world impact of granulocyte-colony stimulating factor on febrile neutropenia
    Altwairgi, A. K.
    Hopman, W. M.
    Mates, M.
    CURRENT ONCOLOGY, 2013, 20 (03) : E171 - E179
  • [24] Granulocyte colony-stimulating factors for febrile neutropenia prophylaxis following chemotherapy: systematic review and meta-analysis
    Katy L Cooper
    Jason Madan
    Sophie Whyte
    Matt D Stevenson
    Ron L Akehurst
    BMC Cancer, 11
  • [25] Granulocyte colony-stimulating factors for febrile neutropenia prophylaxis following chemotherapy: systematic review and meta-analysis
    Cooper, Katy L.
    Madan, Jason
    Whyte, Sophie
    Stevenson, Matt D.
    Akehurst, Ron L.
    BMC CANCER, 2011, 11
  • [26] Effects of primary granulocyte-colony stimulating factor prophylaxis on the incidence of febrile neutropenia in patients with germ cell tumors
    Hapakova, Nikola
    Chovanec, Michal
    Rejlekova, Katarina
    Kalavska, Katarina
    Obertova, Jana
    Palacka, Patrik
    De Angelis, Valentina
    Svetlovska, Daniela
    Sycova-Mila, Zuzana
    Mardiak, Jozef
    Mego, Michal
    ONCOLOGY LETTERS, 2022, 24 (03)
  • [27] Febrile neutropenia and role of prophylactic granulocyte colony-stimulating factor in docetaxel and cyclophosphamide chemotherapy for breast cancer
    Kimura, Yuri
    Sasada, Shinsuke
    Emi, Akiko
    Masumoto, Norio
    Kadoya, Takayuki
    Okada, Morihito
    SUPPORTIVE CARE IN CANCER, 2021, 29 (07) : 3507 - 3512
  • [28] Febrile neutropenia and role of prophylactic granulocyte colony-stimulating factor in docetaxel and cyclophosphamide chemotherapy for breast cancer
    Yuri Kimura
    Shinsuke Sasada
    Akiko Emi
    Norio Masumoto
    Takayuki Kadoya
    Morihito Okada
    Supportive Care in Cancer, 2021, 29 : 3507 - 3512
  • [29] Granulocyte-colony stimulating factor for the prevention of chemotherapy-induced febrile neutropenia in the adult cancer patient population of Southern Israel
    Jacob Gilad
    Klaris Riesenberg
    Wilmosh Mermershtain
    Abraham Borer
    Avi Porath
    F. Schlaeffer
    Supportive Care in Cancer, 1999, 7 : 260 - 264
  • [30] Granulocyte-colony stimulating factor for the prevention of chemotherapy-induced febrile neutropenia in the adult cancer patient population of Southern Israel
    Gilad, J
    Riesenberg, K
    Mermershtain, W
    Borer, A
    Porath, A
    Schlaeffer, E
    SUPPORTIVE CARE IN CANCER, 1999, 7 (04) : 260 - 264
12345